COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Connecticut patients with a documented clinical need may be eligible for compounded tirzepatide.
Connecticut’s proximity to major medical centers in New York and Boston gives residents strong healthcare access. Compounding Finder helps Connecticut patients compare licensed pharmacies that ship throughout the state.
Compounded tirzepatide uses the same active ingredient found in Mounjaro and Zepbound, customizable for patients with documented clinical needs.
Yes. The Connecticut Department of Consumer Protection oversees pharmacy compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.
.png){kind=spacer}
